… awardee Addex Therapeutics has announced a reorganization to increase focus on developing its clinical pipeline for rare and orphan diseases. The company remains committed to the development of dipraglurant … of dipraglurant such as [dyskinesia], anxiety and depression,” he said.  An orphan drug designation provides …

… funds research for Parkinson’s Disease treatments. Before becoming involved with the foundation in 2000, she worked on … became the executive vice chairman. Brooks sat down with Town Square Delaware to discuss how she applies her business … path, I thought, “I feel like there’s something more where I can be of service in a different way. The thing that …

… Alexandra Cherubini was a college undergraduate en route to a semester abroad in Samoa. At the time, she knew little … the years, they’ve supported MJFF financially and hosted pre-race dinners for Team Fox marathoners as well as … leadership can provide updates to supporters in their community. Both Alexandra and Camillo have joined her …

… Attention Bostonians!  Please join the Team Fox Young Professionals of … finding a cure for Parkinson's disease, it's a win-win. Come support a great cause, help the Boston YPs spread awareness, and ultimately have a great time with …

… are selectively eliminated in Parkinson’s disease (PD). To assess this protective activity, we exposed dopamine-producing neurons isolated from pre-clinical models to neurotoxins, and used neurotoxins to … doses of CNM-Au8 or a placebo, and we will then monitor and compare their behavior, metabolite levels, and the survival …

… his diagnosis brought new understanding of PD to the rock world ― and inspired generosity. Two years later, along …